Biodiversity Is Pharma’s Largest, Oldest And Most Under-Priced Supplier
Direct Source Verification:
This story is aggregated from Forbes (forbes.com). Full reporting rights and copyright belong to the primary publisher.
Until companies start to fund nature restoration & governments create the right incentives to unlock private finance, a healthy pipeline of breakthrough drugs is at risk.
For complete coverage, context, and related multimedia, visit the original reporting by Forbes via the source link below.
Original Source
https://www.forbes.com/sites/ninaseega/2026/09/21/biodiversity-is-pharmas-largest-oldest-and-most-under-priced-supplier/
